CFAM
GILD icon

Center For Asset Management’s Gilead Sciences GILD Stock Holding History

Center For Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-18,448
Closed -$1.55M – 127
2024
Q3 		$1.55M Buy
18,448
+285
+2% +$21.7K 0.92% 31
2024
Q2 		$1.25M Buy
18,163
+584
+3% +$39K 0.82% 30
2024
Q1 		$1.29M Buy
17,579
+203
+1% +$15.6K 1.05% 25
2023
Q4 		$1.41M Sell
17,376
-1,568
-8% -$122K 1.28% 20
2023
Q3 		$1.42M Buy
18,944
+48
+0.3% +$3.69K 1.42% 18
2023
Q2 		$1.46M Buy
18,896
+8,269
+78% +$659K 1.38% 17
2023
Q1 		$882K Sell
10,627
-6,246
-37% -$517K 0.86% 29
2022
Q4 		$1.45M Sell
16,873
-1,134
-6% -$89.8K 1.35% 15
2022
Q3 		$1.11M Buy
18,007
+2,418
+16% +$152K 1.1% 17
2022
Q2 		$964K Buy
15,589
+7,843
+101% +$486K 0.89% 20
2022
Q1 		$461K Buy
7,746
+4,135
+115% +$264K 0.36% 55
2021
Q4 		$262K Buy
+3,611
New +$249K 0.19% 99

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Center For Asset Management's GILD Position: Q4 2024 in Review

Center For Asset Management sold out of Gilead Sciences (GILD) in Q4 2024, closing a stake of 18,448 shares — an estimated $1.55M sold.

Center For Asset Management first reported a position in GILD in Q4 2021 and held it in 12 quarters. The position peaked at $1.55M in Q3 2024. 1,888 funds tracked by Wall St. Rank hold GILD as of Q4 2024.

  • Center For Asset Management reported no remaining Gilead Sciences position as of Q4 2024 after selling out during the quarter.
  • Center For Asset Management sold 18,448 Gilead Sciences shares in Q4 2024, an estimated $1.55M.
  • Center For Asset Management first reported a position in Gilead Sciences in Q4 2021 and held it in 12 quarters.
  • Center For Asset Management's Gilead Sciences position peaked at $1.55M in Q3 2024.
  • 1,888 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.

Based on Center For Asset Management's 13F filing for Q4 2024, filed 22 Jan 2025.